Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BAX
BAXTER INTERNATIONAL INC.
NYSE
$26.13
▲ UP 0.77% (0.20)

KEY STATISTICS

Market Cap$13.51 B
52w High$30.00
52w Low$15.73
Dividend Yield0.15%
FrequencyQuarterly
P/E12.56
Volume3.96M
Shares Out.517.00M

COMPANY

LEADERSHIP

Andrew Hider
CHIEF EXECUTIVE
Andrew Hider

COMPENSATION 2026

Salary$660,420
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$7,005,624
Total$7,666,044

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 27, 1981
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
37,500

PRICE TARGET

Target High$28.00
Target Low$21.00
Target Median$25.00
Target Consensus$25.00

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$2.91B
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2015-07-01Forward1841:1000
2001-05-31Forward2:1
1992-12-01Forward100000:90823
1983-11-18Forward2:1
1981-11-09Forward2:1

PRICE

$26.13 ▲ UP 0.77% (+$0.20)
OVERLAYS
$25.80$25.95$26.10$26.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM26.13

About Baxter International Inc.

https://www.baxter.com ↗

Baxter International Inc. develops global healthcare products—including dialysis, infusion, surgical, and monitoring devices, plus connected care solutions—serving hospitals, clinics, and patients worldwide across various medical fields.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT BAXTER INTERNATIONAL INC. IS KNOWN FOR

Norepinephrine Bitartrate in 5% Dextrose Injection
Norepinephrine Bitartrate in 5% Dextrose Injection

Baxter's FDA-approved ready-to-use norepinephrine improves patient safety and efficiency by eliminating manual mixing, offering a critical, stable medication for treating severe hypotension in adults.

COMPETITORS

COMPETITOR
AMRX COMPARE
BDX COMPARE
FMS COMPARE
ICUI COMPARE
PFE COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Medical Products And Therapies$1.33B $1.39B ▲$1.28B ▼$2.08B ▲
Healthcare Systems and Technologies$773M $827M ▲$705M ▼$801M ▲
Pharmaceuticals$632M $668M ▲$621M ▼—

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$1.54B $1.55B ▲$1.44B ▼$1.59B ▲
NonUS— — $1.27B $1.36B ▲
Western Europe Canada Japan Australia and New Zealand$936M $1.02B ▲— —
EMEA$355M $398M ▲— —

ETFS HOLDING THIS STOCK

ETFS HOLDING
407
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.02% · 16.5M
RSP
0.24% · 9.3M
XAW.TO
0.01% · 6.9M
SPY
0.02% · 6.4M
XDEE.SG
0.24% · 1.5M
SCHM
0.25% · 1.4M
DFAS
0.12% · 745.0K
ZLU.TO
0.71% · 521.6K
FSMD
0.26% · 258.3K
RECS
0.10% · 242.0K
BBMC
0.28% · 231.5K
JHMM
0.10% · 230.2K
NOEQ
0.43% · 155.0K
HSPD.L
0.04% · 148.4K
PZ
PZLV
5.20% · 143.8K
SPYI
0.02% · 95.8K
QUS.AX
0.24% · 93.8K
BKMC
0.34% · 84.8K
S500.PA
0.03% · 81.3K
VETS
0.32% · 80.0K
GPIX
0.04% · 77.6K
AVUS
0.01% · 74.3K
IQSM
0.53% · 70.6K
CVGD
1.14% · 62.1K
S5SD.DE
0.03% · 56.0K
SSO
0.01% · 47.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
94.17%
HOLDERS
1,416
TOP 12 OF 1,416 · RANKED BY POSITION SIZE
Blackrock, Inc.
84.8M sh · $1.62B
Pzena Investment Management LLC
70.0M sh · $1.34B
Blackrock Inc.
63.0M sh · $2.11B
Vanguard Group Inc
62.6M sh · $1.2B
Dodge & Cox
58.4M sh · $1.24B
Fmr LLC
53.9M sh · $1.15B
State Street Corp
22.5M sh · $430.95M
Blackrock Institutional Trust Company, N.A.
16.5M sh · $733.01M
Greenhaven Associates Inc
14.3M sh · $240.37M
Geode Capital Management, LLC
14.1M sh · $300.59M
Price T Rowe Associates Inc /Md/
13.5M sh · $306.31M
Invesco Ltd.
13.1M sh · $220.44M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2026-05-01
 Michael McCaul
Michael McCaul
Purchase
2026-03-23
 Lisa McClain
Lisa McClain
Sale
2025-10-31
 Rob Bresnahan
Rob Bresnahan
Purchase
2025-05-15

INSIDER TRADES

★
DIRECTOR
Craig Jeffrey A
Purchase · 12.8K shares
2026-05-05
★
DIRECTOR
Ampofo William A. II
Purchase · 12.8K shares
2026-05-05
★
DIRECTOR
SCHLICHTING NANCY M
Purchase · 12.8K shares
2026-05-05
★
DIRECTOR
McDonnell Michael R.
Purchase · 12.8K shares
2026-05-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 3
NEUTRAL 3
EQUAL WEIGHT 1
OUTPERFORM 1
OVERWEIGHT 1
UNDERWEIGHT 1
10 GRADES IN THE LAST 12 MONTHS
Wells Fargo EQUAL WEIGHT TD Cowen HOLD Citigroup NEUTRAL Stifel HOLD UBS NEUTRAL Goldman Sachs NEUTRAL Evercore ISI Group OUTPERFORM Barclays OVERWEIGHT

SECTORS PEERS

PEERPRICE
MDGL$533.76COMPARE
DVA$180.68COMPARE
BIO$387.70COMPARE
RGEN$176.27COMPARE
AVTR$14.58COMPARE
QGEN$43.11COMPARE
ATR$132.99COMPARE
HIMS$28.84COMPARE